Genetic Polymorphisms in Cytochrome P450 Enzymes: Effect on Efficacy and Tolerability of HMG-CoA Reductase Inhibitors

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.4, Iss.4, 2004-01, pp. : 247-255

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of Genetic Polymorphisms on the Efficacy of HMG-CoA Reductase Inhibitors

By Hutz Mara H.

American Journal of Cardiovascular Drugs, Vol. 8, Iss. 3, 2008-01 ,pp. : 161-170

Adis International

Access to resources Recommend Favorite

Comparative Tolerability of the HMG-CoA Reductase Inhibitors

By Farmer J.A. Torre-Amione G.

Drug Safety, Vol. 23, Iss. 3, 2000-09 ,pp. : 197-213

Adis International

Access to resources Recommend Favorite

The effect of HMG-CoA reductase inhibitors on chronic allograft rejection

By Jones T.

Expert Opinion on Emerging Drugs, Vol. 6, Iss. 1, 2001-04 ,pp. : 95-109

Informa Healthcare

Access to resources Recommend Favorite

Genetic polymorphisms of cytochrome P450 enzymes and antidepressant metabolism

By Porcelli Stefano Fabbri Chiara Spina Edoardo Serretti Alessandro De Ronchi Diana

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 9, 2011-09 ,pp. : 1101-1115

Informa Healthcare

Access to resources Recommend Favorite

The Effects of HMG-CoA Reductase Inhibitors on Endothelial Function

By Tesfamariam Belay

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 2, 2006-01 ,pp. : 115-120

Adis International

Access to resources Recommend Favorite